Rainmaker vs Abridge

Side-by-side comparison of AI visibility scores, market position, and capabilities

Abridge leads in AI visibility (41 vs 28)
Rainmaker logo

Rainmaker

EmergingFinance

General

NYC YC W23 DeFi mobile wallet making yield investing accessible via account abstraction; $31.3M total ($25M Lowercarbon Series A May 2025 + 2024 seed) with auto-compounding positions competing with Coinbase Wallet for mainstream DeFi adoption.

AI VisibilityBeta
Overall Score
D28
Category Rank
#902 of 1158
AI Consensus
68%
Trend
up
Per Platform
ChatGPT
22
Perplexity
26
Gemini
23

About

Rainmaker is a New York City-based DeFi mobile wallet — backed by Y Combinator (W23) with $31.3 million in total funding including a $25 million Series A in May 2025 from Lowercarbon Capital and others, following a 2024 seed from Starship Ventures, Long Journey Ventures, and Day One Ventures — providing mainstream users with an account-abstraction-based mobile crypto wallet that reduces the complexity of DeFi investing to a few taps, enabling auto-compounding yield positions with performance fees (similar to Beefy.finance) and planning subscription services and integrated tax reporting. Founded in 2023 and backed by Y Combinator W23, Rainmaker targets the mass market of potential DeFi participants who are deterred by wallet complexity, gas fee management, and protocol interaction barriers.

Full profile
Abridge logo

Abridge

EmergingHealthcare

General

Pittsburgh ambient clinical AI (founded by cardiologist) at $5.3B valuation Jun 2025; $800M total ($300M a16z/Khosla Series E) deployed at UPMC 12K clinicians, Mayo Clinic, Johns Hopkins competing with Nuance DAX for physician documentation.

AI VisibilityBeta
Overall Score
C41
Category Rank
#777 of 1158
AI Consensus
50%
Trend
up
Per Platform
ChatGPT
35
Perplexity
49
Gemini
33

About

Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao.

Full profile

AI Visibility Head-to-Head

28
Overall Score
41
#902
Category Rank
#777
68
AI Consensus
50
up
Trend
up
22
ChatGPT
35
26
Perplexity
49
23
Gemini
33
34
Claude
51
32
Grok
38

Key Details

Category
General
General
Tier
Emerging
Emerging
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.